Patent classifications
A61B5/4094
SYSTEM FOR RECORDING OF SEIZURES
A system includes an EEG headset, comprising EEG electrodes and InfraRed (IR) transmitters, to be worn by a subject. A recording unit is communicably coupled to the EEG headset and comprises a computing device for receiving EEG feed from the EEG headset, IR coordinates corresponding to the IR transmitters from an IR sensor, and a video recording of the subject from a video camera. The computing device is to identify a position of the subject based on the IR coordinates or the video recording or a combination thereof; cause the computing device to be reoriented based on the position of the subject; and facilitate detection and recording of seizure events based on the EEG feed or video recording or IR coordinates or a combination thereof. The computing device provides a seizure event report based on detection of the seizure events.
SYSTEM, PROCESS, AND DEVICES FOR REAL-TIME BRAIN MONITORING
Systems, processes and devices for real-time brain monitoring to generate and control an interface of a display device with a visual representation of a Brain Value Index for entropy, a connectivity map and treatment guidance. Systems, processes and devices for real-time brain monitoring capture sensor data, process the data and dynamically update the interface in real-time.
Method and system for electrode impedance measurement
The present invention relates to measuring electrical impedance, and particularly to measuring impedance of electrodes used to acquire physiological signals. The measurement of electrode impedance is typically performed to ensure proper electrode-to-skin contact, and thus verify the quality of the acquired signals. Electrode-to-skin contact impedance has also clinical utility for monitoring, diagnosis, prognosis or treatment, as it can be used to measure skin conductivity, which is function of physiological processes. The present invention relates in particular to a substantially continuous method for performing such measurement. The measurement is performed in such a way that it does not affect the bioband, the range (or ranges) of frequencies that contains components used for diagnostic, prognostic, triage, and/or treatment purposes. The present invention therefore performs this impedance measurement without affecting the physiological signal while allowing for uninterrupted monitoring of said signal.
DETECTION, LOCALIZATION, AND/OR SUPPRESSION OF NEURAL ACTIVITY USING ACOUSTIC WAVES AND/OR ULTRASOUND
Systems and methods are disclosed related to using acoustic waves to detect neural activity in a brain and/or localize the neural activity in the brain. Sensors positioned outside of a skull encasing the brain can detect acoustic waves associated with the neural activity in the brain. From output signals of the sensors, a particular type of neural activity (e.g., a seizure) can be detected. A location of the neural activity can be determined based on outputs of the sensors. In some embodiments, the ultrasound energy can be applied to the location of the neural activity in response to detecting the neural activity.
METHOD FOR GENERATING STIMULATION PARAMETERS, ELECTRICAL STIMULATION CONTROL APPARATUS AND ELECTRICAL STIMULATION SYSTEM
A method for generating stimulation parameters, an electrical stimulation control apparatus and an electrical stimulation system are provided. After receiving a brainwave signal, the brainwave signal is decomposed to obtain a first sub-signal and a second sub-signal. Then, the first sub-signal is analyzed to obtain an intrinsic frequency series, and the second sub-signal is converted to a Boolean signal. Subsequently, the intrinsic frequency series and the Boolean signal, which serve as a set of stimulation parameters, are outputted to the stimulator, enabling the stimulator to generate a stimulus signal.
DEVICE AND METHOD FOR PREVENTING SUDDEN DEATH AND PROTECTING OXYGEN STATUS DURING SEIZURE ACTIVITY
The present disclosure relates to a system for prevention of sudden death that includes a wearable seizure detection device; a base unit; and a computer, the computer configured to receive input from the seizure detection device and trigger the base unit to release oxygen under a condition effective to enrich an environmental oxygen level and prevent sudden death when the input indicates a seizure. Also disclosed is a portable system for preventing sudden death, where the system includes an oronasal mask; a compressed oxygen cartridge, wherein the compressed oxygen cartridge is coupled to the oronasal mask; and a fastener, wherein the fastener is coupled to the oronasal mask, wherein the system releases oxygen upon activation under a condition effective to enrich an environmental oxygen level and prevent sudden death. Further disclosed are methods of preventing sudden death comprising enriching an environmental oxygen level for a subject using the systems described.
Augmented reality display system for evaluation and modification of neurological conditions, including visual processing and perception conditions
In some embodiments, a display system comprising a head-mountable, augmented reality display is configured to perform a neurological analysis and to provide a perception aid based on an environmental trigger associated with the neurological condition. Performing the neurological analysis may include determining a reaction to a stimulus by receiving data from the one or more inwardly-directed sensors; and identifying a neurological condition associated with the reaction. In some embodiments, the perception aid may include a reminder, an alert, or virtual content that changes a property, e.g. a color, of a real object. The augmented reality display may be configured to display virtual content by outputting light with variable wavefront divergence, and to provide an accommodation-vergence mismatch of less than 0.5 diopters, including less than 0.25 diopters.
Apparatus, systems and methods for delivery of medication to the brain to treat neurological conditions
Various embodiments provide an apparatus, system method for treating neurological conditions by delivering solid form medication to the ventricles or other areas of the brain. Particular embodiments provide an apparatus and method for treating epilepsy and other neurological conditions by delivering solid form medication to ventricles in the brain wherein the medication is contained in a diffusion chamber so as to allow the medication to dissolve in the cerebrospinal fluid of the brain and then diffuse out of the diffusion chamber to be delivered to the ventricles and brain tissue. In one or more embodiments, portions of apparatus have sufficient flexibility to conform to the shape of the ventricles of the brain when advanced into them and/or to not cause deformation of the ventricle sufficient to cause a significant physiologic effect.
Apparatus and method for decoding and restoring cognitive functions
A hippocampal prosthesis for bypassing a damaged portion of a subject's hippocampus and restoring the subject's ability to form long-term memories. The hippocampal prosthesis includes a first set of hippocampal electrodes configured to receive an input signal from at least one of the subject's hippocampus or surrounding cortical region. The hippocampal prosthesis includes a processing device having a memory and one or more processors operatively coupled to the memory and to the first set of hippocampal electrodes. The processing device being configured to generate an output signal based on the input signal received from the first set of hippocampal electrodes. The hippocampal prosthesis includes a second set of hippocampal electrodes operatively coupled to the one or more processors and configured to receive and transmit the output signal to the subject's hippocampus.
CONTINGENT CARDIO-PROTECTION FOR EPILEPSY PATIENTS
Disclosed are methods and systems for treating epilepsy by stimulating a main trunk of a vagus nerve, or a left vagus nerve, when the patient has had no seizure or a seizure that is not characterized by cardiac changes such as an increase in heart rate, and stimulating a cardiac branch of a vagus nerve, or a right vagus nerve, when the patient has had a seizure characterized by cardiac changes such as a heart rate increase.